Treatment of the Newly Diagnosed Adult with De Noyo Acute Myeloid Leukemia
- 1 February 1993
- journal article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 7 (1) , 47-64
- https://doi.org/10.1016/s0889-8588(18)30257-0
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Comparative cellular pharmacology of daunorubicin and idarubicin in human multidrug-resistant leukemia cellsBlood, 1992
- Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis [see comments]Blood, 1992
- Recombinant human granulocyte-macrophage colony-stimulating factor after chemotherapy in patients with acute myeloid leukemia at higher age or after relapseBlood, 1991
- Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemiaBlood, 1991
- Recombinant human granulocyte-macrophage colony-stimulating factor in combination with standard induction chemotherapy in de novo acute myeloid leukemiaBlood, 1991
- Etoposide in leukemiaCancer, 1991
- Treatment of relapsed and refractory acute myeloid leukemia with diaziquone and mitoxantrone: A CALGB phase I studyAmerican Journal of Hematology, 1990
- High-dose etoposide and cyclophosphamide without bone marrow transplantation for resistant hematologic malignancyBlood, 1990
- Chemotherapy v marrow transplantation for adults with acute nonlymphocytic leukemia: a five-year follow-upBlood, 1988
- Allogeneic marrow transplantation for acute nonlymphoblastic leukemia after first relapseBlood, 1983